ADMA BIOLOGICS, INC. (26)

Browse by Contract Category

Contracts

Amendment No. 2 to Sale Agreement, dated as of February 3, 2021 (Filed With SEC on February 3, 2021)
Rights Agreement, dated as of December 16, 2020, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 16, 2020)
Amendment 1 to the Amended and Restated Agreement for Services, effective as of September 25, 2017, by and between ADMA Biologics, LLC and Areth LLC (Filed With SEC on March 13, 2020)
Amendment #1 to Transition Services Agreement, dated as of August 29, 2019, by and between ADMA Biomanufacturing, LLC and Biotest Pharmaceuticals Corporation (Filed With SEC on September 5, 2019)
Amendment No. 2 to Credit Agreement and Guaranty, dated December 8, 2020 (Filed With SEC on December 9, 2020)
Note, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on December 9, 2020)
Amendment to Open Market Sale AgreementSM, dated November 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on November 5, 2020)
Open Market Sale AgreementSM, dated August 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on August 5, 2020)
Note, dated March 20, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 20, 2020)
Amendment 3 to the Amended and Restated Agreement for Services, effective as of November 7, 2019, by and between ADMA Biologics, LLC and Areth LLC (Filed With SEC on March 13, 2020)
Amendment 2 to the Amended and Restated Agreement for Services, effective as of September 27, 2018, by and between ADMA Biologics, LLC and Areth LLC (Filed With SEC on March 13, 2020)
Description of Capital Stock of ADMA Biologics, Inc (Filed With SEC on March 13, 2020)
Underwriting Agreement by and among the Company and the Underwriters dated as of February 6, 2020 (Filed With SEC on February 7, 2020)
Underwriting Agreement by and among the Company and the Underwriters dated as of May 16, 2019 (Filed With SEC on May 17, 2019)
Amendment No. 1 to Credit Agreement and Guaranty, dated as of May 3, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA... (Filed With SEC on May 3, 2019)
Warrant to Purchase Stock, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)
Note, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)
Transition Services Agreement, dated as of January 1, 2019, by and between the Company and Biotest Pharmaceuticals Corporation (Filed With SEC on March 13, 2019)
Security Agreement, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and Perceptive... (Filed With SEC on February 12, 2019)
Credit Agreement and Guaranty, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and... (Filed With SEC on February 12, 2019)
Warrant to Purchase Stock, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)
Note, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)
Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Brian Lenz (Filed With SEC on January 29, 2019)
Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Dr. James Mond (Filed With SEC on January 29, 2019)
Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Adam Grossman (Filed With SEC on January 29, 2019)
Fifth Amendment to Plasma Purchase Agreement, effective as of January 1, 2019, by and between ADMA Biologics, Inc. and Grifols Worldwide Operations Limited (Filed With SEC on January 2, 2019)